Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2013; 19(6): 855-865
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.855
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.855
Table 4 Number of new intrahepatic recurrence detected by follow-up contrast-enhanced ultrasound and contrast-enhanced computed tomography
CEUS | CECT | ||||||
N | 0 | 1 | 2 | 3 | 4 | 5 | Total |
0 | 69 (0/0) | 13 (0/13) | 7 (0/14) | 1 (0/3) | 0 (0/0) | 0 (0/0) | 90 (0/30) |
1 | 4 (4/0) | 25 (25/25) | 9 (9/18) | 8 (8/24) | 1 (1/4) | 0 (0/0) | 47 (47/71) |
2 | 2 (4/0) | 5 (10/5) | 8 (16/16) | 3 (6/9) | 0 (0/0) | 0 (0/0) | 18 (36/30) |
3 | 0 (0/0) | 0 (0/0) | 0 (0/0 ) | 7 (21/21) | 1 (3/4) | 1 (3/5) | 9 (27/30) |
4 | 0 (0/0) | 0 (0/0) | 0 (0/0) | 0 (0/0) | 3 (12/12) | 1 (4/5) | 4 (16/17) |
5 | 0 (0/0) | 0 (0/0) | 0 (0/0) | 0 (0/0) | 0 (0/0) | 1 (5/5) | 1 (5/5) |
Total | 75 (8/0) | 43 (35/43) | 24 (25/48) | 19 (35/57) | 5 (16/20) | 3 (12/15) | 169 (131/183) |
- Citation: Zheng SG, Xu HX, Lu MD, Xie XY, Xu ZF, Liu GJ, Liu LN. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19(6): 855-865
- URL: https://www.wjgnet.com/1007-9327/full/v19/i6/855.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i6.855